180 related articles for article (PubMed ID: 28611326)
1. Serum Cyfra 21-1 levels in oral squamous cell carcinoma patients and its clinicopathologic correlation.
Singh P; Barpande SR; Bhavthankar JD; Mandale MS; Bhagwat AU
Indian J Dent Res; 2017; 28(2):162-168. PubMed ID: 28611326
[TBL] [Abstract][Full Text] [Related]
2. Detection of serum Cyfra 21-1 in patients with primary oral squamous cell carcinoma.
Zhong LP; Zhu HG; Zhang CP; Chen WT; Zhang ZY
Int J Oral Maxillofac Surg; 2007 Mar; 36(3):230-4. PubMed ID: 16965897
[TBL] [Abstract][Full Text] [Related]
3. Salivary and serum level of CYFRA 21-1 in oral precancer and oral squamous cell carcinoma.
Rajkumar K; Ramya R; Nandhini G; Rajashree P; Ramesh Kumar A; Nirmala Anandan S
Oral Dis; 2015 Jan; 21(1):90-6. PubMed ID: 24304502
[TBL] [Abstract][Full Text] [Related]
4. Serum markers of CYFRA 21-1 and C-reactive proteins in oral squamous cell carcinoma.
Hsu YP; Hsieh CH; Chien HT; Lai CH; Tsao CK; Liao CT; Kang CJ; Wang HM; Chang JT; Huang SF
World J Surg Oncol; 2015 Aug; 13():253. PubMed ID: 26292957
[TBL] [Abstract][Full Text] [Related]
5. Correlation of Cyfra 21-1 levels in saliva and serum with CK19 mRNA expression in oral squamous cell carcinoma.
Malhotra R; Urs AB; Chakravarti A; Kumar S; Gupta VK; Mahajan B
Tumour Biol; 2016 Jul; 37(7):9263-71. PubMed ID: 26779624
[TBL] [Abstract][Full Text] [Related]
6. Increased Cyfra 21-1 concentration in saliva from primary oral squamous cell carcinoma patients.
Zhong LP; Zhang CP; Zheng JW; Li J; Chen WT; Zhang ZY
Arch Oral Biol; 2007 Nov; 52(11):1079-87. PubMed ID: 17612501
[TBL] [Abstract][Full Text] [Related]
7. Serum SCCA, Cyfra 21-1, EGFR and Cyclin D1 levels in patients with oral squamous cell carcinoma.
Feng XY; Li JH; Li JZ; Han ZX; Xing RD
Int J Biol Markers; 2010; 25(2):93-8. PubMed ID: 20586028
[TBL] [Abstract][Full Text] [Related]
8. Serum big endothelin-1 as a biomarker in oral squamous cell carcinoma patients: an analytical study.
Mankapure PK; Barpande SR; Bhavthankar JD; Mandale M
J Appl Oral Sci; 2015 Oct; 23(5):491-6. PubMed ID: 26537720
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Roles of SCC Antigen, CRP and CYFRA 21-1 in Oral Cavity Squamous Cell Carcinoma.
DE Paz D; Young CK; Chien HT; Tsao CK; Fok CC; Fan KH; Liao CT; Wang HM; Kang CJ; Chang JT; Huang SF
Anticancer Res; 2019 Apr; 39(4):2025-2033. PubMed ID: 30952746
[TBL] [Abstract][Full Text] [Related]
10. Follow-up with serum Cyfra 21-1 in patients with squamous cell carcinomas of the head and neck.
Kuropkat C; Lippert BM; Werner JA
Oncology; 2002; 63(3):280-5. PubMed ID: 12381908
[TBL] [Abstract][Full Text] [Related]
11. The Diagnostic and Prognostic Value of Tumor Markers (CEA, SCC, CYFRA 21-1, TPS) in Head and Neck Cancer Patients.
Barak V; Meirovitz A; Leibovici V; Rachmut J; Peretz T; Eliashar R; Gross M
Anticancer Res; 2015 Oct; 35(10):5519-24. PubMed ID: 26408719
[TBL] [Abstract][Full Text] [Related]
12. Cyfra 21-1 as a tumor marker for follow-up of patients with squamous cell carcinoma of the oropharynx.
Alkotyfan K; Wiegand S; Müller HH; Windfuhr JP; Werner JA; Sesterhenn AM
Anticancer Res; 2010 Jun; 30(6):2291-6. PubMed ID: 20651382
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of CYFRA 21-1 in patients with esophageal squamous cell carcinoma.
Shimada H; Nabeya Y; Okazumi S; Matsubara H; Miyazawa Y; Shiratori T; Hayashi H; Gunji Y; Ochiai T
J Am Coll Surg; 2003 Apr; 196(4):573-8. PubMed ID: 12691934
[TBL] [Abstract][Full Text] [Related]
14. Monitoring carcinogenesis in a case of oral squamous cell carcinoma using a panel of new metabolic blood biomarkers as liquid biopsies.
Grimm M; Hoefert S; Krimmel M; Biegner T; Feyen O; Teriete P; Reinert S
Oral Maxillofac Surg; 2016 Sep; 20(3):295-302. PubMed ID: 26875085
[TBL] [Abstract][Full Text] [Related]
15. Circulating Anti-Matrix Metalloproteinase-7 Antibodies May Be a Potential Biomarker for Oral Squamous Cell Carcinoma.
Jiang T; Xie P; Liu H
J Oral Maxillofac Surg; 2016 Mar; 74(3):650-7. PubMed ID: 26454036
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of serum CYFRA 21-1 1 in patients with anal canal squamous cell carcinoma treated with radio(chemo)therapy.
Gauthé M; Richard-Molard M; Rigault E; Buecher B; Mariani P; Bellet D; Cacheux W; Lièvre A
BMC Cancer; 2018 Apr; 18(1):417. PubMed ID: 29653564
[TBL] [Abstract][Full Text] [Related]
17. [Usefulness of the SCC, CEA, CYFRA 21.1, and CRP markers for the diagnosis and monitoring of cervical squamous cell carcinoma].
Chmura A; Wojcieszek A; Mrochem J; Walaszek-Gruszka A; Deja R; Masłyk B; Bartnik W; Sodowski K
Ginekol Pol; 2009 May; 80(5):361-6. PubMed ID: 19548456
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of serum C-reactive protein (CRP) and cytokeratin 19 fragments (Cyfra 21-1) but not carcinoembryonic antigen (CEA) in surgically treated patients with non-small cell lung cancer.
Szturmowicz M; Rudziński P; Kacprzak A; Langfort R; Bestry I; Broniarek-Samson B; Orłowski T
Pneumonol Alergol Pol; 2014; 82(5):422-9. PubMed ID: 25133810
[TBL] [Abstract][Full Text] [Related]
19. Increased serum placenta growth factor level is significantly associated with progression, recurrence and poor prognosis of oral squamous cell carcinoma.
Cheng SJ; Lee JJ; Cheng SL; Chen HM; Chang HH; Wang YP; Kok SH; Kuo MY; Chiang CP
Oral Oncol; 2012 May; 48(5):424-8. PubMed ID: 22244591
[TBL] [Abstract][Full Text] [Related]
20. CYFRA 21-1: a suitable tumor marker in patients with head and neck cutaneous squamous cell carcinoma?
Rudhart SA; Schultz JD; Gehrt F; Pavel FL; Birk R; Hoch M; Stuck BA; Hoch S
Eur Arch Otorhinolaryngol; 2019 Dec; 276(12):3467-3475. PubMed ID: 31482332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
